James R Anderson, PhD

Associate Dean for Research

Professor
Department of Biostatistics
University of Nebraska Medical Center
College of Public Health

Professional Summary

• 1977 - 1980      University of Southern California College of Medicine
• 1980 - 1989      Harvard University School of Public Health
• 1981 - 1990      Group Statistician, Cancer & Leukemia, Group B (CALGB)
• 1989 - Present   University of Nebraska College of Medicine
• 1995 - Present   Group Statistician, Intergroup Rhabdomyosarcoma Study Group
• 2004 - Present   Group Statistician, Children's Oncology Group

Education

• PhD   Biomathematics, University of Washington, 1979
• BA     Mathematics, State University of New York at Buffalo, 1973

Research Interest & Projects

• Design and analysis of clinical trials, especially cancer clinical trials; statistical and practical issues related to interim monitoring of clinical trials results and Data and Safety Monitoring Committees.
• Studies of the treatment of childhood cancer, especially soft tissue sarcoma and renal cell tumors.
• Ethical issues, including those related to Institutional Review Boards, in the conduct of clinical trials research.

Selected Publications

• Arndt C, Hawkins D, Anderson JR, Breitfeld P, Womer R, Meyer W.  Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide.  J Clin Oncol. 22:1894-901, 2004.
• Sung L, Anderson JR, Donaldson SS, Spunt SL, Crist WM, Pappo AS.  Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Eur J Cancer. 2004 Aug;40(12):1878-85.
• Rupp ME, Fitzgerald T, Marion N, Helget V, Puumala S, Anderson JR, Fey PD.  Effect of silver-coated urinary catheters: Efficacy, cost-effectiveness, and antimicrobial resistance.  Am J Infect Control, 34:445-50, 2004.
• Chiu B C-H, Kolar C, Gapstur SM, Lawson T, Anderson JR, Weisenburger DD. Association of NAT and GST polymorphisms with non-Hodgkins lymphoma: a population-based case-control study. British J Haematology 128:610-15, 2005.
• Enose Y, Destache CJ, Mack AL, Anderson JR, Ullrich F, Ciborowski PS, Gendelman HE. Proteomic fingerprints distinguish microglia, bone marrow, and spleen macrophage populations.  Glia. 51(3):161-72, 2005.
• Donaldson SS, Anderson JR. Rhabdomyosarcoma: many similarities, a few philosophical differences (editorial). J Clin Oncol. 2005 Apr 20;23(12):2586-7.
• Anderson JR (letter). More on data monitoring and large apparent treatment effects. Contemp Clin Trials 26:416-17, 2005.

Professional Affiliations

• Children's Oncology Group